healthcare

Patients who've learned their genetic risk of disease worry about healthcare law changes in the US, Kaiser Health News reports.

According to ASHG, the final rules, issued this week, will significantly weaken patient privacy protections under ADA and GINA.

The companies are working together to help insurers reduce wasteful spending and spur use of medically necessary tests. 

Patronus will use BaseHealth's platform to provide health assessments based on patients' genomics, medical histories, and environmental risk factors.

A medical genetics practice's lawsuit against a government insurance administrator points to continued uncertainty about reimbursement for NGS testing in Germany.

Recent cost analyses funded by Ariosa and Natera found that NIPT could replace conventional screening in the US and be cost-neutral if provided at certain prices.

OKP will pay for testing if standard first trimester screening indicates a risk higher than 1:1000 for trisomies 21, 18, or 13.

The collaborators will explore how InterSystems' HealthShare health informatics platform can support genomic and clinical data integration and analysis

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

The University Funds, which operates under a "venture-development" model, has a $50 million investment fund and is reviewing research and intellectual property from UA and six other partner institutions with the goal of forming 10 companies.

Pages

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.